The aim of this study was to assess and compare the safety and efficacy performance of two commercial vaccines registered in Canada, under field conditions, on a commercial farm where E. coli was found to be the source of diarrhea.
Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm
Publications
Swine
Appeared in
AASV Congress, 2017
This study shows differing diarrhea-preventive effects of the two vaccines evaluated. SUISENG® vaccine exhibited a 6-fold lower incidence of diarrhea in suckling piglets from gilts vaccinated with it than in suckling piglets from gilts vaccinated with its competitor, Vaccine B. SUISENG® vaccine also showed greater safety than Vaccine B by causing a smaller increase in post-vaccination body temperature and by not showing any local or general type reactions, which may end in abortion.
Download this article
Related products
The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection
Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet
Purified recombinant verotoxin 2e against edema disease, in suspension for injection
Inactivated vaccine, against progressive and non progressive swine atrophic rhinitis, in injectable suspension.
Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension
Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.
Inactivated vaccine against porcine parvovirus and swine erysipelas, in injectable suspension
Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension
Live vaccine against Aujeszky’s disease gE negative strain, in injectable freeze-dried tablet
Inactivated vaccine against swine erysipelas, in injectable suspension
Inactivated porcine against porcine parvovirus, in injectable suspension
Inactivated vaccine against enzootic pneumonia, in injectable suspension
Related services
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Swine, the HIPRA SMART VACCINATION is spearheaded by our innovative MHYOSPHERE® PCV ID and UNISTRAIN® PRRS vaccines, the needle-free intradermal device Hipradermic® and the professional veterinary app HIPRAlink® Vaccination.
An innovative service based on data analysis that facilitates decision-making in swine
HIPRA Stats is a data analysis service for animal production companies.
Hipradermic® is an advanced needle-free injection device with wireless connectivity for the intradermal vaccination of pigs.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
